On this page you'll find 4 example sentences with Pulmatrix. Discover how to use the word correctly in a sentence.
Pulmatrix in a sentence
Context around Pulmatrix
- Average sentence length in these examples: 22.5 words
- Position in the sentence: 2 start, 0 middle, 2 end
- Sentence types: 4 statements, 0 questions, 0 exclamations
Corpus analysis for Pulmatrix
- In this selection, "pulmatrix" usually appears near the start of the sentence. The average example has 22.5 words, and this corpus slice is mostly made up of statements.
- Around the word, raised, stock and posted stand out and add context to how "pulmatrix" is used.
- Recognizable usage signals include coverage for pulmatrix and pulmatrix posted earnings. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "pulmatrix" sits close to words such as aaas, aacc and aacs, which helps place it inside the broader word index.
Example types with pulmatrix
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
A hedge fund recently raised its stake in Pulmatrix stock. (10 words)
Zacks’ earnings per share calculations are a mean average based on a survey of sell-side research firms that that provide coverage for Pulmatrix. (24 words)
Pulmatrix posted earnings per share of ($1.30) in the same quarter last year, which would indicate a positive year-over-year growth rate of 70%. (26 words)
Zacks Investment Research raised Pulmatrix from a “hold” rating to a “buy” rating and set a $1.00 target price for the company in a report on Thursday, August 15th. (30 words)
Pulmatrix posted earnings per share of ($1.30) in the same quarter last year, which would indicate a positive year-over-year growth rate of 70%. (26 words)
Zacks’ earnings per share calculations are a mean average based on a survey of sell-side research firms that that provide coverage for Pulmatrix. (24 words)
Example sentences (4)
Zacks’ earnings per share calculations are a mean average based on a survey of sell-side research firms that that provide coverage for Pulmatrix.
A hedge fund recently raised its stake in Pulmatrix stock.
Pulmatrix posted earnings per share of ($1.30) in the same quarter last year, which would indicate a positive year-over-year growth rate of 70%.
Zacks Investment Research raised Pulmatrix from a “hold” rating to a “buy” rating and set a $1.00 target price for the company in a report on Thursday, August 15th.